Bioscience Evidence 2024, Vol.14, No.3, 131-142 http://bioscipublisher.com/index.php/be 137 to expand the catalytic repertoire of enzymes (Wu et al., 2019). These examples highlight the transformative impact of directed evolution in developing highly efficient and versatile biocatalysts for various applications (Denard et al., 2015; Zeymer and Hilvert, 2018; Chen and Arnold, 2020). 6.3 Integration of synthetic biology and directed evolution The integration of synthetic biology with directed evolution has opened new avenues for enzyme engineering. Synthetic biology provides a toolkit for constructing and manipulating genetic circuits, enabling the precise control of gene expression and metabolic pathways (Zeymer and Hilvert, 2018). This integration allows for the systematic exploration of enzyme functions and the creation of novel biocatalytic systems. For example, the use of synthetic biology techniques to design and stabilize reaction intermediates has facilitated the development of catalytically promiscuous enzymes, which can perform multiple, mechanistically distinct transformations (Leveson-Gower et al., 2019). Additionally, computational methods, including machine learning and ensemble modeling, have been employed to predict and design enzyme variants with desired properties, further enhancing the efficiency of directed evolution (Wu et al., 2019; Broom et al., 2020; Planas-Iglesias et al., 2021). By combining the strengths of synthetic biology and directed evolution, researchers can achieve unprecedented levels of enzyme performance and create biocatalysts tailored for specific industrial and biomedical applications (Kaur and Sharma, 2006; Chen and Arnold, 2020). 7 Challenges and Limitations 7.1 Technical challenges in mutagenesis and screening One of the primary technical challenges in directed evolution is the generation of genetic diversity through mutagenesis and the subsequent screening of enzyme variants. Traditional methods such as error-prone PCR and DNA shuffling can be labor-intensive and time-consuming, often requiring extensive screening to identify beneficial mutations (Hoebenreich et al., 2015; Zeymer and Hilvert, 2018). Although ultrahigh-throughput screening (uHTS) methods have been developed to address these issues, they still face limitations in terms of compartmentalization and maintaining the genotype-phenotype link (Agresti et al., 2010; Markel et al., 2019). Additionally, the quality of combinatorial libraries can vary significantly depending on the method used, with solid-phase gene synthesis often producing less biased libraries compared to PCR-based methods. 7.2 Limitations of current synthetic biology tools Despite significant advancements, current synthetic biology tools still have limitations that hinder the efficiency of directed evolution. For instance, the choice of mutagenesis strategy can greatly impact the quality of the resulting enzyme libraries. Iterative saturation mutagenesis (ISM) has shown promise in improving enzyme properties, but it requires careful selection of mutagenesis sites and codon degeneracy to be effective (Reetz and Carballeira, 2007; Reetz et al., 2008; Reetz et al., 2010). Moreover, the integration of continuous hypermutation systems like OrthoRep with high-throughput screening is still in its early stages and may not be universally applicable to all enzymes or pathways (Figure 3) (Jensen et al., 2020). 7.3 Scalability and reproducibility issues Scalability and reproducibility are significant concerns in directed evolution experiments. While uHTS platforms can screen millions of variants in a short time, the reproducibility of these results can be affected by factors such as the consistency of droplet formation in microfluidics and the stability of the screening environment (Agresti et al., 2010). Additionally, the scalability of directed evolution is often limited by the need for extensive manual intervention in mutagenesis and screening processes, which can introduce variability and reduce reproducibility (Kumar and Singh, 2013). 7.4 Ethical and regulatory considerations The application of synthetic biology and directed evolution in enzyme engineering raises several ethical and regulatory issues. The potential for creating novel enzymes with unknown properties necessitates stringent regulatory oversight to ensure safety and environmental protection (Kumar and Singh, 2013). Moreover, the use of genetically modified organisms (GMOs) in industrial applications is subject to regulatory frameworks that vary
RkJQdWJsaXNoZXIy MjQ4ODYzMg==